Specialty pharmaceutical company that manufactures generic, brand and biologic drugs
H.R. 1427 - to amend the Public Health Service Act to provide for the liscensing of biosimilar and biogeneric biological products, and for other purposes. 
S. 726 - to amend the Public Health Service Act to provide for the liscensing of biosimilar and biogeneric biological products, and for other purposes. H.R. 3590 Patient Protection and Affordable Care Act 
H.R. 4872 The Health Care and Education Reconcilation Act of 2010 H.R. 1706 - To prohibit brand name drug companies from compensating generic drug companies to delay the entry of generic drug in to the market, and for other purposes. 
S. 369 - A bill to prohibit brand name drug companies from compensating generic drug companies to delay the entry of generic drug in to the market, and for other purposes. S. 515 A bill to amend title 35, United States Code, to provide Patent Reform
S. 610 - A bill to amend title 35, United States Code, to provide for Patent Reform
H.R. 1260 - to amend title 35, United States Code, to provide for Patent Reform
HCR - Health Issues LBR - Labor Issues/Antitrust/Workplace CPT - Copyright/Patent/Trademark
2 - HOUSE OF REPRESENTATIVES 1 - SENATE 2 - HOUSE OF REPRESENTATIVES 1 - SENATE 2 - HOUSE OF REPRESENTATIVES 1 - SENATE
LOPER CONSULTING LLC
4551 32nd Road North, Arlington, VA, 22207, US
GINGER LOPER GINGER LOPER GINGER LOPER